Skip to main content
US lawmakers call for reconsideration of India's cardiac stent price cap

A group of 18 US lawmakers sent a letter to India's ambassador to Washington asking the country to reconsider its price cap on cardiac stents, because the policy could hamper citizens' access to innovative medical devices and discourage medtech companies from releasing new products in India. "We are especially worried that comments by government officials signal the intention to double down on this dangerous policy and expand price cuts to other medical devices," the lawmakers wrote.

Full Story: